Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 12/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | CLK1 | P49759 | 3/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5397339 | 0.91 | ADORA1 (0.57) | ADORA1ADORA2AGFERKMT2ALMNA | |
| SCHEMBL4760405 | 0.86 | MAPK1 (0.58) | ADORA1ADORA2AGFERKMT2AMAPK1 | |
| SCHEMBL5397397 | 0.83 | ADORA1 (0.66) | ADORA1ADORA2AGFERKMT2ACLK1 | |
| SCHEMBL5401957 | 0.81 | ADORA1 (0.66) | ADORA1ADORA2AMAPK1MAPK10 | |
| SCHEMBL5400627 | 0.81 | MAPK1 (0.54) | ADORA1ADORA2AGFERKMT2AMAPK1 | |
| SCHEMBL5399205 | 0.78 | ADORA1 (0.48) | ADORA1ADORA2AGFERKMT2ACLK1 | |
| SCHEMBL16893055 | 0.77 | ADORA1 (0.49) | ADORA1ADORA2AGFERKMT2ALMNA | |
| SCHEMBL5410470 | 0.77 | ADORA1 (0.65) | ADORA1ADORA2AKMT2AMAPK1MAPK10 | |
| SCHEMBL5407380 | 0.77 | MAPK1 (0.48) | ADORA1ADORA2AGFERKMT2AMAPK1 | |
| SCHEMBL5396690 | 0.75 | AURKA (0.42) | ADORA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100534991-C | Heterocyclic inhibitors of ERK 2 and uses thereof | VERTEX PHARMA (US) | 2009-09-02 | — | — | CN | claimed |
| CN-1494541-A | heterocyclic inhibitors of ERK2 and uses thereof | ��̩��˹ҩ��ɷ�����˾ | 2004-05-05 | — | — | CN | claimed |